Success Stories: EB-1A Approved for Technical Director in Washington in the Field of Cell and Molecular Biology
On March 16th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Technical Director in the Field of Cell and Molecular Biology (Approval Notice)
Position at the Time of Case Filing: Technical Director
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Washington
Approval Notice Date: March 16th, 2015
Processing Time: 2 Months, 4 Days (11 Days after Premium Processing Requested)
In this case, the client that we had the opportunity to work with was a Technical Director from China in the field of Cell and Molecular Biology. His specialized research has focused on biomaterials, cell and molecular biology in yeast and zebrafish, and molecular biology as applied to pharmacogenetic diagnostics. His work had resulted in 10 peer-reviewed scientific articles and at least 6 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 502 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 31 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] effort could have saved over a thousand Americans from suffering adverse drug reactions. This innovative process could not have been completed without the undeviating participation of [client] and his cell and molecular biology proficiency. Seeing as this is an ongoing endeavor, due to the success of this process, a patent is being considered for filing.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Cell and Molecular Biology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 2 months and 4 days.